PyInvesting

Market research

4952.TSE SDS Biotech K.K

TSE JPY Basic Materials

Latest close

— —

Latest stored close unavailable

Test a moving-average rule with historical data.

Market facts
Market cap
11B
P/E ratio
Not available
Analyst target
Not available
Dividend yield
1.7%
Beta
0.96

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 7 months ago

SDS Biotech K.K is currently in a long term uptrend where the price is trading 32.7% above its 200 day moving average.

From a valuation standpoint, the stock is 7.4% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.7.

SDS Biotech K.K's total revenue sank by 3.2% to $3B since the same quarter in the previous year.

Its net income has increased by 49.3% to $422M since the same quarter in the previous year.

Based on the above factors, SDS Biotech K.K gets an overall score of 3/5.